Rmb Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Rmb Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $181,303 - $211,092	-663 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $35,053 - $48,533	-117 Reduced 15.0%	663 $208,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $23,068 - $27,253	62 Added 8.64%	780 $320,000
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $71,983 - $83,744	-205 Reduced 22.21%	718 $290,000
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $2,846 - $3,449	10 Added 1.1%	923 $0
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $139,276 - $173,656	-441 Reduced 32.57%	913 $314,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $154,569 - $202,548	431 Added 46.7%	1,354 $509,000
Q2 2017 Aug 14, 2017	BUY	N/A	923	923 $453,000

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.